Although there is so much evidence that NUP37 was a risk factor for the prognosis of glioma, we try to further explore the relationship between NUP37 and known biomarkers in glioma, which provide more evidence to support NUP37 as a malignant molecule. This evidence concerns the gene NUP37 and central nervous system cancer.